There are 2789 resources available
776P - SHR-1701, a bifunctional fusion protein targeting PD-L1 and TGF-β, for pretreated advanced cervical cancer: Data from a clinical expansion cohort of a phase I study
Presenter: Jifeng Feng
Session: ePoster Display
777P - A prospective, single-arm, open-label study of camrelizumab, apatinib and nab-paclitaxel in patients with advanced cervical cancer
Presenter: guiling Li
Session: ePoster Display
778P - BYL719 (alpelisib) for the treatment of PIK3CA-mutated, recurrent/advanced cervical cancer
Presenter: Giorgio Bogani
Session: ePoster Display
779P - Metronomic low-dose capecitabine in metastatic, recurrent or persistent carcinoma of cervix as 3rd line and beyond
Presenter: Irappa Madabhavi
Session: ePoster Display
781P - Efficacy and safety of apatinib combined with chemotherapy in patients of cervical cancer with pulmonary metastasis
Presenter: Shuai Feng
Session: ePoster Display
782P - A retrospective study of toripalimab combined with concurrent chemoradiotherapy in patients with recurrent/advanced cervical cancer
Presenter: Yan Cheng
Session: ePoster Display
784P - Survival outcomes in cervical cancer: What factors affect recurrence?
Presenter: Christine Wang
Session: ePoster Display
785P - Clinical characteristics and prognostic nomogram for adenosquamous carcinoma of the cervix: A study of 1142 patients
Presenter: Pengfei Cui
Session: ePoster Display